Reports

Thomas Brenzikofer

Thomas Brenzikofer

Manager Network and Events, Healthcare Innovation - DayOne


Tel. +41 61 295 50 16

thomas.notexisting@nodomain.combrenzikofer@baselarea.notexisting@nodomain.comswiss
report Precision Medicine
DNA. (Img: PublicDomainPictures/Pixabay)

DNA. (Img: PublicDomainPictures/Pixabay)

12.01.2018

Genedata launches new solution for CRISPR experiments

Basel-based software firm Genedata has launched a new solution for data management and analysis of CRISPR experiments. Currently available software tools have been insufficient until now.

Genedata develops software for scientific applications. The latest product from the Basel-based company is the Genedata Selector for Precise Genome Editing. According to a company statement, the integrated software product is designed for data management and analysis of CRISPR-related genomic data.

Genome editing techniques like CRISPR/Cas9 technology modify the DNA of genes that are responsible for causing diseases. The method was developed by the French geneticist Emmanuelle Charpentier and the American biologist Jennifer Doudna, and her technology was named breakthrough of the year in 2015 by the journal Science.

According to Genedata, currently available software tools for CRISPR applications address only individual steps of the entire experimental process and make the data analysis process very manual and therefore prone to errors. The Genedata Selector for Precise Genome Editing in contrast is a comprehensive software solution that maximises the likelihood of successful and precise CRISPR experiments.

The software makes it possible to store genome data from other experiments and studies, allowing them to be used for comparisons. The data can also be exchanged on a secure platform, all the while maintaining full IP protection.

“I am really excited of this latest advancement of Genedata Selector as it provides organizations, who invest in CRISPR technology, a sophisticated data management and analysis solution for faster and more effective research and product development results,” said Othmar Pfannes, CEO of Genedata.

Cookies

BaselArea.swiss uses cookies to ensure you get the best service on our website.
By continuing to browse the site, you are agreeing to the use of cookies.

Ok